Dongkook Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dongkook Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 24 500 KRW 0.41% Market Closed

Market Cap: ₩1.1T

D	Dongkook Pharmaceutical Co Ltd KOSDAQ:086450	KR
S	Sunstone Hotel Investors Inc SWB:UF2	US
S	Scor SE DUS:SDRC	FR
	Andean Precious Metals Corp TSX:APM	CA
	Safran SA F:SEJU	FR

Profitability Summary

Dongkook Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

56% > 55%

Healthy Operating Margin

10%

Low 3Y Average Operating Margin

10%

Operating Margin is Increasing

9% > 10%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

7% > 8%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-1% > 3%

Positive ROE

12%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.